type in your search and press enter
AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids
You May Also Like
Celldex Reports Fourth Quarter and Year-End 2015 Results
HAMPTON, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...
China In-Vitro Diagnostics (IVD) Market 2007-2017 & 2018-2024: Cost Factor Restricts the Contribution of Global IVD Companies in the Chinese IVD Market
Dublin, Jan. 07, 2019 (GLOBE NEWSWIRE) -- The "China In-Vitro Diagnostics (IVD) Market, By ...
electroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public Offering
BASKING RIDGE, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a ...
